It promotes aggressive behavior in NSCLC and prostate cancer via activation of ERK/MYC and STAT3 signaling [19,20], respectively, while in medullary thyroid carcinoma, it correlates with nodal spread through YAP1 suppression [21]. Here, STAT3 is linked to prostate carcinoma.